My project is on the production of a novel beer using non-traditional yeasts. At later stages, we are considering large scale production and commercialization.

The issue is, some of the yeast species that I am working on are not present in the Qualified Presumption of Safety (QPS) list of the European Food Safety Authority (EFSA), or in the Generally Recognized as Safe (GRAS) list of FDA. Although, there are articles and/or patents on their use for beer/wine production and they are present in IDF/EFFCA inventory of microbial food cultures.

The sources I found are a little confusing as I am not very familiar with this process.

My main question is, is having a QPS or GRAS status necessary for a species for their use in commercial production?

For a deeper understanding, my further questions are:

  • Is it the same for filtered beer, even if the microorganism will not be in the final product?
  • If we apply for QPS/GRAS, how long the process takes? - From my understanding, EFSA is updating their evaluation every 6 months, and their list every 3 years. Therefore, if I apply for a new species, the earliest possible approval would be in their next list?
  • Should we apply for QPS/GRAS for a new strain of a QPS/GRAS species if we want to commercialize?
  • If the new species belong to the same genus, would it help with the process? (For example, Lindnera jadinii is on the list, would it make it easier for Lindnera saturnus?)
  • Is the absence of toxic/harmful effects on the human, animal, environment is sufficient for this status, or are clinical studies required?
  • Would Anamorph/Teleomorph names of the same species in the list make any difference?

Thank you very much for all your help in advance.

More Emre İlpars's questions See All
Similar questions and discussions